DRUG COUNSELLING TIPS

 

Top 300 drug counselling tips:

1. Carvidelol:

Continued pescribed dose

Cause drowsiness.

Masks symptoms of hypoglycemia. 

Do not discontinue abruptly.

Avoid alcohol intake 

2. Pregabalin:

Cause drowsiness or dizziness

Avoid alcohol intake

Side effects:  

Edema

Weight gain 

Mental confusion

3. Sumitriptan:

Take at onset of migraine. If headache is relieved but returns after 1st dose, repeat in 2 hours.

Do not exceed 2 doses or 200mg in a 24 hour period.

If 1st dose does not relieve symptoms, reevaluate condition. 

Ischemic cardiovascular events possible. Drug interactions with ergot derivatives.               

4.Alprazolam:

Do not exceed prescribed dose

Do not take with alcohol

Cause drowsiness or dizziness

Do not operate heavy machinery

Do not discontinue abruptly

5. Fentynl:

Caution for respiratory depression

Do not exceed prescribed dose. 

Avoid exposing patch on the skin to heat as it will increase the delivery of the fentanyl and increase the risk of toxicity.

Dispose of the used patch by folding over and flushing it.

Be careful when starting therapy and remember the patch is used for several days normally 72 hours but may see it changed every 48 hours in some patients. 

6. Morphine:

Risk of CNS and respiratory depression avoid alcohol intake

Cause drowsiness or dizziness

Do not operate heavy machinery

Cause constipation

7. Ibuprofen:

Take with food

Sometime chance of GI bleeding

Cardio vascular and renal risks. 

8. Misoprostol:

Take with food

Misoprostol may decrease GI bleeding risks. 

Cardio vascular  and renal risks. 

Avoid in pregnancy.

Cause Diarrhea                   

9. Celeoxib:

Sometime chance of GI bleed

Caution for CV risk like all NSAIDS

Not safer for renal function but may be slightly safer for GI bleeding risks

10. Tramadol:

Cause drowsiness

Avoid alcohol intake

Some risk of dependence due to weak opioid receptor agonist activity. 

Drug also has some serotonin reuptake inhibitor properties; caution against GI effects, serotonin syndrome, increased seizure risk, and drug interactions (especially with SSRIs, SNRIs, 5-HT1 agonists/triptans)